305 related articles for article (PubMed ID: 34280248)
1. Skeletal muscle mass at C3 may not be a strong predictor for skeletal muscle mass at L3 in sarcopenic patients with head and neck cancer.
Yoon JK; Jang JY; An YS; Lee SJ
PLoS One; 2021; 16(7):e0254844. PubMed ID: 34280248
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of using head and neck CT imaging to assess skeletal muscle mass in head and neck cancer patients.
Swartz JE; Pothen AJ; Wegner I; Smid EJ; Swart KM; de Bree R; Leenen LP; Grolman W
Oral Oncol; 2016 Nov; 62():28-33. PubMed ID: 27865369
[TBL] [Abstract][Full Text] [Related]
4. Validation of skeletal muscle mass assessment at the level of the third cervical vertebra in patients with head and neck cancer.
Bril SI; Chargi N; Wendrich AW; Wegner I; Bol GH; Smid EJ; de Jong PA; Devriese LA; de Bree R
Oral Oncol; 2021 Dec; 123():105617. PubMed ID: 34749251
[TBL] [Abstract][Full Text] [Related]
5. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer.
Chang SW; Tsai YH; Hsu CM; Huang EI; Chang GH; Tsai MS; Tsai YT
PLoS One; 2021; 16(5):e0251455. PubMed ID: 33970954
[TBL] [Abstract][Full Text] [Related]
6. A prediction model for skeletal muscle evaluation and computed tomography-defined sarcopenia diagnosis in a predominantly overweight cohort of patients with head and neck cancer.
Vangelov B; Bauer J; Moses D; Smee R
Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):321-328. PubMed ID: 35835910
[TBL] [Abstract][Full Text] [Related]
7. The use of alternate vertebral levels to L3 in computed tomography scans for skeletal muscle mass evaluation and sarcopenia assessment in patients with cancer: a systematic review.
Vangelov B; Bauer J; Kotevski D; Smee RI
Br J Nutr; 2022 Mar; 127(5):722-735. PubMed ID: 33910664
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
Vangelov B; Bauer J; Moses D; Smee R
Head Neck; 2022 May; 44(5):1047-1056. PubMed ID: 35138008
[TBL] [Abstract][Full Text] [Related]
9. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.
Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765
[TBL] [Abstract][Full Text] [Related]
10. Utility of multidetector computed tomography quantitative measurements in identifying sarcopenia: a propensity score matched study.
Zuo YQ; Gao ZH; Wang Z; Liu Q; Yang X; Yin YL; Feng PY
Skeletal Radiol; 2022 Jun; 51(6):1303-1312. PubMed ID: 34757481
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle mass at C3 is a strong predictor for skeletal muscle mass at L3 in sarcopenic and non-sarcopenic patients with head and neck cancer.
Bril SI; van Beers MA; Chargi N; Carrillo Minulina N; Smid EJ; Dankbaar JW; de Bree R
Oral Oncol; 2021 Nov; 122():105558. PubMed ID: 34627078
[No Abstract] [Full Text] [Related]
12. Skeletal muscle mass and sarcopenia can be determined with 1.5-T and 3-T neck MRI scans, in the event that no neck CT scan is performed.
Zwart AT; Becker JN; Lamers MJ; Dierckx RAJO; de Bock GH; Halmos GB; van der Hoorn A
Eur Radiol; 2021 Jun; 31(6):4053-4062. PubMed ID: 33219847
[TBL] [Abstract][Full Text] [Related]
13. Interobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebra.
Bril SI; Wendrich AW; Swartz JE; Wegner I; Pameijer F; Smid EJ; Bol GH; Pothen AJ; de Bree R
Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1175-1182. PubMed ID: 30689037
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia in head and neck cancer: A scoping review.
Jovanovic N; Chinnery T; Mattonen SA; Palma DA; Doyle PC; Theurer JA
PLoS One; 2022; 17(11):e0278135. PubMed ID: 36441690
[TBL] [Abstract][Full Text] [Related]
15. The use of the second thoracic vertebral landmark for skeletal muscle assessment and computed tomography-defined sarcopenia evaluation in patients with head and neck cancer.
Vangelov B; Bauer J; Moses D; Smee R
Head Neck; 2023 Apr; 45(4):1006-1016. PubMed ID: 36811256
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma.
Chargi N; Bril SI; Swartz JE; Wegner I; Willems SM; de Bree R
Oral Oncol; 2020 Feb; 101():104519. PubMed ID: 31855705
[TBL] [Abstract][Full Text] [Related]
17. Thoracic skeletal muscle index is effective for CT-defined sarcopenia evaluation in patients with head and neck cancer.
Vangelov B; Smee R; Moses D; Bauer J
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5583-5594. PubMed ID: 37573279
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia and its impact in head and neck cancer treatment.
de Bree R; van Beers MA; Schaeffers AWMA
Curr Opin Otolaryngol Head Neck Surg; 2022 Apr; 30(2):87-93. PubMed ID: 35255045
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Fat Mass and Skeletal Muscle Mass Determined by Computed Tomography in Patients Who Underwent Transcatheter Aortic Valve Implantation.
Mok M; Allende R; Leipsic J; Altisent OA; Del Trigo M; Campelo-Parada F; DeLarochellière R; Dumont E; Doyle D; Côté M; Freeman M; Webb J; Rodés-Cabau J
Am J Cardiol; 2016 Mar; 117(5):828-33. PubMed ID: 26754122
[TBL] [Abstract][Full Text] [Related]
20. The validation of low-dose CT scans from the [
Zwart AT; Cavalheiro VJ; Lamers MJ; Dierckx RAJO; de Bock GH; Halmos GB; van der Hoorn A
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1735-1742. PubMed ID: 36781423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
